GE vs TERN · P/E 44, rev $45.85B vs $6.12B cap
GE Aerospace (GE) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
GE Aerospace (GE) is a aerospace & defense company listed on NYSE. It is led by Larry Culp.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported GE revenue for 2025-12-31 was $45.85B. Net income was $8.70B. Revenue was up 324.1% from 2024-12-31 to 2025-12-31. GE currently screens at market cap $373.04B and trailing P/E 44.4.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
GE currently screens at market cap $373.04B and trailing P/E 44.4. TERN currently screens at market cap $6.12B.
Not investment advice. Open the GE and TERN stock pages for the full models.
Not investment advice.